Advertisement
UK markets open in 3 hours 44 minutes

  • NIKKEI 225

    37,780.35
    +151.87 (+0.40%)
     

  • HANG SENG

    17,605.32
    +320.78 (+1.86%)
     

  • CRUDE OIL

    83.83
    +0.26 (+0.31%)
     

  • GOLD FUTURES

    2,346.10
    +3.60 (+0.15%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • Bitcoin GBP

    51,522.55
    +216.51 (+0.42%)
     

  • CMC Crypto 200

    1,392.59
    +10.02 (+0.72%)
     

  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     

  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Insights on the Auto-Injectors Global Market to 2026 - Featuring Antares Pharma, Mylan & Amgen Among Others

Research and Markets
·4-min read

Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Auto-Injectors Market Global Forecast by Regions, Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types, Distribution Channels, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

This report studies the global market for auto-injectors and offers a thorough overview of the growth drivers and barriers, industry trends, leading players and their future predictions.

An auto-injector is a diagnostic device that is used for the treatment of allergies. It works as the injection which is given at the accurate depth and through which patients feel comfortable comparing to manual syringes. As the auto-injector is a modern developed device, so they are more preferred over conventional devices these days. According to this research analysis, it is predicted that by 2026, the Global Auto-Injector Market will be US$ 5.8 billion.

According to the product basis, the auto-injector market is classified by the prefilled and fillable injector. According to usability, the market was categorized into disposable and reusable injectors. The combined growth of these injectors technologically sustains the growth of the auto-injectors market globally. The most restraining factors of the auto-injector market are the side effects of the drugs, which affect human intolerance.

The United States allergy is counted as the sixth leading cause of critical cause of chronic illness. North America region held a dominant position in the global auto-injectors market share in 2019. The market in Europe is witnessing increasing shortages of epinephrine auto-injectors following manufacturing issues with the Emerade brand auto-injector. Therefore, critical companies in the market can focus on expanding their presence in the region.

May 2020, the Kaleo Company has relaunched the auto-injector in Canada. The federal governments of the states were stepping forward for the approvals of the auto-injectors market in the globe. Another imitative taken in Aug 2020 by Antares Pharma and Lunatus has entered in countries like Saudi Arabia and UAE for the distribution of the drugs in the market. Due to the widespread of the coronavirus virus across the globe, it has affected the supply-chain system of the auto-injectors market globally.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Growth Drivers
3.1 Increasing number of Chronic Disease
3.2 Increasing Prevalence of Food Allergy
3.3 Government Initiatives
3.4 Decline in Price of Epipen

4 Challenges
4.1 Unmet Needs in Allergic Care
4.2 Regulatory Hurdle in United States

5 Global Auto-Injectors Market

6 Market Share - Global Auto-Injectors
6.1 Geographical Regions
6.2 Application
6.3 Product Type
6.4 Usability
6.5 Distribution Channels

7 Regions - Auto-Injectors Market
7.1 North America
7.2 Asia Pacific
7.3 Europe
7.4 Middle East & Africa

8 Application - Auto-Injectors Market
8.1 Anaphylaxis
8.2 Multiple Sclerosis
8.3 Rheumatoid Arthritis
8.4 Others

9 Product Type - Auto-Injectors Market
9.1 Prefilled Auto-Injectors
9.2 Fillable Auto-Injectors

10 Usability - Auto-Injectors Market
10.1 Reusable Auto-Injectors
10.2 Disposable Auto-Injectors

11 Distribution Channels - Auto-Injectors Market
11.1 Online Pharmacies
11.2 Retail Pharmacies
11.3 Others

12 Company Analysis
12.1 Antares Pharma, Inc
12.1.1 Company Overview
12.1.2 Company Initiatives & Recent Developments
12.1.3 Financial Insight
12.2 Mylan N.V. - Company Analysis
12.2.1 Company Overview
12.2.2 Company Initiatives & Recent Developments
12.2.3 Financial Insight
12.3 Amgen Inc.
12.3.1 Company Overview
12.3.2 Company Initiatives & Recent Developments
12.3.3 Financial Insight
12.4 Novartis AG
12.4.1 Company Overview
12.4.2 Company Initiatives & Recent Developments
12.4.3 Financial Insight
12.5 Bayer AG
12.5.1 Company Overview
12.5.2 Company Initiatives & Recent Developments
12.5.3 Financial Insight

For more information about this report visit https://www.researchandmarkets.com/r/o07y3m

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

ADVERTISEMENT
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900